Virion Therapeutics Company
Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virally-associated cancers.
Investors
Founded Date:
2018-01-01
Total Funding:
14075858
Funding Status:
Early Stage Venture
Last Funding Type:
Debt Financing
Investors Number:
7
Last Funding Date:
2020-08-24
Industry:
Viral Vectors
Headquarters:
Newark, Delaware, United States
Estimated Revenue:
Less than $1M